BioCentury
ARTICLE | Clinical News

Asunaprevir regulatory update

November 11, 2013 8:00 AM UTC

Bristol-Myers submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for an interferon- and ribavirin-free oral regimen of daclatasvir and asunaprevir to treat chronic HCV genotype 1...